Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROPHYLACTIC TREATMENT FOR CHEMO-INDUCED NEUTROPENIA. USE OF G-CSF BIOSIMILAR (NIVESTIM(REGISTERED)) ACCORDING TO THE CHEMOTHERAPY CONTEXT: ADJUVANT VERSUS METASTATIC.

NCT02454530 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT02454530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02454530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROPHYLACTIC TREATMENT FOR CHEMO-INDUCED NEUTROPENIA. USE OF G-CSF BIOSIMILAR (NIVESTIM(REGISTERED)) ACCORDING TO THE CHEMOTHERAPY CONTEXT: ADJUVANT VERSUS METASTATIC.
Lead sponsor
Pfizer
Phase
Observational
Overall status
Terminated
Start date
September 30, 2014
Completion date
January 31, 2017
Enrollment
1,160 (actual)
Sites
92

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced neutropenia